Drawing all the Benefits from Pharmaceutical Spending
OECD countries' pharmaceutical policies generally focus on three main objectives: making medicines accessible and affordable to patients; containing public spending growth, and providing incentives for future innovation. This chapter provides a brief review of current pharmaceutical reimbursement and pricing policies in OECD countries, as well as short‐term measures adopted in response to the economic crisis. It then focuses in particular on two important issues: decisions pertaining to the coverage of new products with high costs and/or uncertain benefits, and the development of generic markets.
No Supplementary Data
No Article Media
Document Type: Review Article
Publication date: 2010-10-01